Browsing by Subject "A1,3 strain"
Now showing items 1-1 of 1
-
(2010-11-17)The potential of human 20S proteasome inhibitors continues to be of interest for anticancer chemotherapy and the recent FDA approval of bortezomib (Velcade) validates the proteasome as a target for cancer chemotherapy. ...